Emergence of a multidrug-resistant Haemophilus influenzae strain causing chronic pneumonia in a patient with common

Yvonne Pfeifer1, Ines Meisinger, Klaus Brechtel

  • 1Robert-Koch-Institute, FG13 Nosocomial Infections, Wernigerode, Germany.

Microbial Drug Resistance (Larchmont, N.Y.)
|October 26, 2012
PubMed

Insights

A multidrug-resistant Haemophilus influenzae strain emerged in an immunodeficient patient with recurrent pneumonia. Genetic analysis revealed resistance mechanisms to beta-lactams, macrolides, and fluoroquinolones.

Area of Science:

  • Medical Microbiology
  • Genetics
  • Immunology

Background:

  • Common variable immunodeficiency (CVID) predisposes patients to recurrent infections.
  • Haemophilus influenzae is a significant cause of respiratory tract infections, particularly in immunocompromised individuals.

Observation:

  • A patient with CVID developed recurrent bronchopneumonia due to H. influenzae.
  • Following multiple antibiotic treatments, an H. influenzae strain exhibited resistance to ampicillin, beta-lactam/beta-lactamase inhibitor combinations, cephalosporins, and macrolides.

Findings:

  • Genetic analysis identified the bla(TEM-1) gene conferring beta-lactam resistance.
  • Mutations in ftsI (A502T, R517H) and ribosomal protein L4 (G65D) conferred resistance to beta-lactams and macrolides, respectively.
  • The plasmid-borne aac(6')-Ib-cr gene and mutations in gyrA and parC genes resulted in high-level fluoroquinolone resistance.

Implications:

  • Treatment of H. influenzae infections with high bacterial loads can lead to the selection of multidrug-resistant strains.
  • The emergence of aac(6')-Ib-cr may contribute to the selection of fluoroquinolone resistance in H. influenzae.
  • Understanding these resistance mechanisms is crucial for managing infections in immunocompromised patients.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: